- Total Second Quarter Revenues Increase 21% to $7.4 Million
- WatchPATTM Revenues Increase 16% in the Second Quarter to $6.5 Million
- Company to Host Conference Call Today at 8:00 am ET, 3:00 pm IT
Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a company that develops, manufactures and markets non-invasive diagnostic medical devices for sleep apnea with a focus on the cardiology market, today reported unaudited financial results for the three months and sixmonth periods ended June 30, 2019.